NYSE:PRGOPharmaceuticals
Will Perrigo’s (PRGO) Q2 Profit Rebound and Reaffirmed Guidance Reshape Its Investment Narrative?
Perrigo Company plc recently reported its second-quarter 2026 results, showing US$1,022.8 million in sales versus US$1,056.3 million a year earlier and a shift from a US$8.4 million net loss to a US$74.5 million net income, while also reaffirming full-year 2026 guidance for an All In net sales growth decline of 1.5% to 5.5%.
Alongside these results, Perrigo’s board maintained its quarterly dividend at US$0.29 per share, signaling ongoing capital returns even as year-to-date sales of...